BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20825416)

  • 21. Global levels of histone modifications predict prostate cancer recurrence.
    Ellinger J; Kahl P; von der Gathen J; Rogenhofer S; Heukamp LC; Gütgemann I; Walter B; Hofstädter F; Büttner R; Müller SC; Bastian PJ; von Ruecker A
    Prostate; 2010 Jan; 70(1):61-9. PubMed ID: 19739128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ginsenoside Rg3 inhibits renal cell carcinoma cell migration, invasion, colony formation, and tube formation and enhances apoptosis through promoting the DNA demethylation and histone acetylation.
    Ma Z; Zuo Y; Wang W
    J Pharm Pharmacol; 2023 Jan; 75(1):76-86. PubMed ID: 36264186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lactate Increases Renal Cell Carcinoma Aggressiveness through Sirtuin 1-Dependent Epithelial Mesenchymal Transition Axis Regulation.
    Miranda-Gonçalves V; Lameirinhas A; Macedo-Silva C; Lobo J; C Dias P; Ferreira V; Henrique R; Jerónimo C
    Cells; 2020 Apr; 9(4):. PubMed ID: 32340156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and epigenetic regulatory mechanism of BNIP3 in clear cell renal cell carcinoma.
    Shao Y; Liu Z; Liu J; Wang H; Huang L; Lin T; Liu J; Wei Q; Zeng H; He G; Li X
    Int J Oncol; 2019 Jan; 54(1):348-360. PubMed ID: 30365137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomas.
    Xu X; Jin H; Liu Y; Liu L; Wu Q; Guo Y; Yu L; Liu Z; Zhang T; Zhang X; Dong X; Quan C
    Diagn Pathol; 2012 Mar; 7():33. PubMed ID: 22455563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global histone modifications predict prognosis of resected non small-cell lung cancer.
    Barlési F; Giaccone G; Gallegos-Ruiz MI; Loundou A; Span SW; Lefesvre P; Kruyt FA; Rodriguez JA
    J Clin Oncol; 2007 Oct; 25(28):4358-64. PubMed ID: 17906200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
    Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
    Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells.
    Park KC; Heo JH; Jeon JY; Choi HJ; Jo AR; Kim SW; Kwon HJ; Hong SJ; Han KS
    BMC Cancer; 2015 Jan; 15():19. PubMed ID: 25613585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients.
    Song JS; Kim YS; Kim DK; Park SI; Jang SJ
    Pathol Int; 2012 Mar; 62(3):182-90. PubMed ID: 22360506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of single-dose injections of modafinil and methamphetamine on epigenetic and functional markers in the mouse medial prefrontal cortex: potential role of dopamine receptors.
    González B; Torres OV; Jayanthi S; Gomez N; Sosa MH; Bernardi A; Urbano FJ; García-Rill E; Cadet JL; Bisagno V
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():222-234. PubMed ID: 30056065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704.
    Manuyakorn A; Paulus R; Farrell J; Dawson NA; Tze S; Cheung-Lau G; Hines OJ; Reber H; Seligson DB; Horvath S; Kurdistani SK; Guha C; Dawson DW
    J Clin Oncol; 2010 Mar; 28(8):1358-65. PubMed ID: 20142597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry.
    Kim SH; Park WS; Park EY; Park B; Joo J; Joung JY; Seo HK; Lee KH; Chung J
    PLoS One; 2017; 12(6):e0179610. PubMed ID: 28654655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UHRF1 promotes renal cell carcinoma progression through epigenetic regulation of TXNIP.
    Jiao D; Huan Y; Zheng J; Wei M; Zheng G; Han D; Wu J; Xi W; Wei F; Yang AG; Qin W; Wang H; Wen W
    Oncogene; 2019 Jul; 38(28):5686-5699. PubMed ID: 31043707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.
    Tamagawa H; Oshima T; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Masuda M; Imada T; Miyagi Y
    Oncol Rep; 2012 Mar; 27(3):637-42. PubMed ID: 22076537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
    Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI
    Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Lin TC
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. H4K12 and H3K18 Acetylation Associates With Poor Prognosis in Pancreatic Cancer.
    Juliano CN; Izetti P; Pereira MP; Dos Santos AP; Bravosi CP; Abujamra AL; Prolla PA; Osvaldt AB; Edelweiss MI
    Appl Immunohistochem Mol Morphol; 2016; 24(5):337-44. PubMed ID: 26067135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Piwi-like 1 protein expression is a prognostic factor for renal cell carcinoma patients.
    Stöhr CG; Steffens S; Polifka I; Jung R; Kahlmeyer A; Ivanyi P; Weber F; Hartmann A; Wullich B; Wach S; Taubert H
    Sci Rep; 2019 Feb; 9(1):1741. PubMed ID: 30741998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo.
    Juengel E; Makarević J; Tsaur I; Bartsch G; Nelson K; Haferkamp A; Blaheta RA
    PLoS One; 2013; 8(1):e53100. PubMed ID: 23372654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
    Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
    Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.